Ascending Single-dose Study to Evaluate TVB-2640 in Chinese Healthy Subjects
Clinical trial NCT04352361 · COMPLETED
Trial details
- NCT number
- NCT04352361
- Sponsor
- Ascletis Pharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-02
- Primary completion
- 2020-04-29
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.